指南与共识心血管MR

心肌炎患者早期钆增强:使用单剂0.1mmol/Kg高弛豫率钆对比剂验证「Lake Louise共识」标准

Early myocardial gadolinium enhancement in patients with myocarditis: Validation of "Lake Louise consensus" criteria using a single bolus of 0.1mmol/Kg of a high relaxivity gadolinium-based contrast agent.
指南 / 共识 · Eur J Radiol · 2017-07-27

本研究回顾性纳入54例疑似心肌炎患者,在临床症状出现四周内行心脏磁共振和心内膜心肌活检,评估高弛豫率对比剂钆贝葡胺(0.1mmol/Kg)用于早期钆增强检测心肌充血的表现。以活检为参考,标准阈值EGEr>4.0的敏感度0.61、特异度0.85、准确率0.70;EGEr的AUC为0.701,绝对增强的AUC为0.706。作者结论认为高弛豫率对比剂在心肌炎早期钆增强评估中提供与标准弛豫率螯合物相当的结果。

要点

  • 标准阈值EGEr>4.0诊断心肌炎的敏感度0.61、特异度0.85、准确率0.70。
  • EGEr的AUC为0.701(95%CI 0.556-0.846,p=0.014),绝对增强AUC为0.706(95%CI 0.563-0.849,p=0.012)。
  • 心肌水肿的敏感度0.67、特异度0.80、准确率0.72;晚期钆增强的敏感度0.76、特异度0.75、准确率0.76。

核心结论

  • 高弛豫率对比剂在心肌炎早期钆增强评估中提供与标准弛豫率螯合物相当的结果。

研究设计与样本

  • 回顾性纳入54例疑似心肌炎患者(平均年龄44.1岁,范围18-77岁,72%为男性),在临床症状出现四周内行心脏磁共振和心内膜心肌活检。

关键影像表现/征象

  • 早期钆增强采用自由呼吸心电门控Turbo自旋回波T1加权序列,在钆贝葡胺0.1mmol/Kg给药前及给药后前三分钟内采集。
  • 计算心肌与骨骼肌早期增强比值(EGEr)。
  • 心肌水肿、早期钆增强和晚期钆增强均与心内膜心肌活检结果进行相关性分析。

诊断标准与关键数值

  • 标准早期钆增强阈值EGEr>4.0诊断心肌炎的敏感度0.61、特异度0.85、准确率0.70。
  • EGEr的ROC曲线下面积AUC为0.701(95%CI 0.556-0.846,p=0.014)。
  • 绝对增强的ROC曲线下面积AUC为0.706(95%CI 0.563-0.849,p=0.012)。
  • 心肌水肿的敏感度0.67、特异度0.80、准确率0.72。
  • 晚期钆增强的敏感度0.76、特异度0.75、准确率0.76。

临床应用与阅片要点

  • 作者结论认为高弛豫率对比剂在心肌炎早期钆增强评估中提供与标准弛豫率螯合物相当的结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Global early gadolinium enhancement (EGE) is an accepted cardiac magnetic resonance (CMR) criterion for diagnosis of myocarditis. However, recommended enhancement thresholds are based specifically on standard-relaxivity Gd-chelates. We evaluated the performance of a high relaxivity MR contrast agent for detection of myocardial hyperemia in patients referred for endomyocardial biopsy (EMB).

METHODS: We retrospectively enrolled 54 patients (mean age: 44.1 years [range=18-77years]; 72% men) with suspected myocarditis who underwent CMR and EMB within four weeks of clinical onset. CMR imaging protocol included T2-weighted short tau inversion-recovery sequence, EGE and late gadolinium enhanced (LGE) imaging. For EGE imaging, free-breathing ECG-gated turbo spin echo T1-weighted (TSE T1w) sequences were acquired before and within the first three minutes after gadobenate dimeglumine (0.1mmol/Kg) administration. The ratio (EGEr) between myocardial and musculoskeletal early enhancement was calculated. Myocardial edema, EGE and late gadolinium enhancement (LGE) were correlated with EMB results. Receiver operating characteristic (ROC) curve analysis of EGE values was applied on the overall population.

RESULTS: EMB revealed myocarditis in 34/54 patients. Sensitivity, specificity and accuracy values of 0.61, 0.85 and 0.70, respectively, were obtained for a standard EGE threshold (EGEr>4.0). ROC analysis revealed an area under the curve of 0.701 for EGEr (IC95%:0.556-0.846, p=0.014) and 0.706 for absolute enhancement (IC95%:0.563-0.849, p=0.012). Sensitivity, specificity and accuracy values were 0.67, 0.80 and 0.72, respectively, for myocardial edema and 0.76, 0.75 and 0.76, respectively, for LGE.

CONCLUSIONS: High relaxivity contrast agents provide comparable results to standard-relaxivity chelates for EGE assessment in diagnosing myocarditis.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Galea N, Francone M, Fiorelli A, et al. Early myocardial gadolinium enhancement in patients with myocarditis: Validation of "Lake Louise consensus" criteria using a single bolus of 0.1mmol/Kg of a high relaxivity gadolinium-based contrast agent. Eur J Radiol. 2017. PMID: 28987703. doi:10.1016/j.ejrad.2017.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。